KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Inventory Average (2018 - 2025)

Historic Inventory Average for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to $8.0 million.

  • Aquestive Therapeutics' Inventory Average rose 1445.63% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 1445.63%. This contributed to the annual value of $6.4 million for FY2024, which is 210.38% up from last year.
  • Latest data reveals that Aquestive Therapeutics reported Inventory Average of $8.0 million as of Q3 2025, which was up 1445.63% from $7.7 million recorded in Q2 2025.
  • Aquestive Therapeutics' 5-year Inventory Average high stood at $8.0 million for Q3 2025, and its period low was $2.6 million during Q1 2021.
  • In the last 5 years, Aquestive Therapeutics' Inventory Average had a median value of $6.5 million in 2023 and averaged $5.8 million.
  • Per our database at Business Quant, Aquestive Therapeutics' Inventory Average plummeted by 1153.72% in 2021 and then surged by 10576.99% in 2022.
  • Aquestive Therapeutics' Inventory Average (Quarter) stood at $3.5 million in 2021, then surged by 81.21% to $6.3 million in 2022, then rose by 10.74% to $6.9 million in 2023, then dropped by 5.65% to $6.5 million in 2024, then grew by 22.53% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q3 2025, $7.7 million for Q2 2025, and $6.6 million during Q1 2025.